AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [11] Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
    Pons, Marion
    Georgiadis, Stylianos
    Ostergaard, Mikkel
    Ahmadzay, Zohra Faizy
    Glintborg, Bente
    Heberg, Jette
    Christensen, Sara Nysom
    Rasmussen, Simon
    Loft, Anne Gitte
    Castrejon, Isabel
    Sanchez-Alonso, Fernando
    Iannone, Florenzo
    Nordstrom, Dan
    Hokkanen, Anna-Mari
    Ciurea, Adrian
    Nissen, Michael J.
    Zavada, Jakub
    Pavelka, Karel
    Rotar, Ziga
    Pirkmajer, Katja Perdan
    Michelsen, Brigitte
    Mielnik, Pawel
    Bernardes, Miguel
    Khmelinskii, Nikita
    Laas, Karin
    Vorobjov, Sigrid
    Codreanu, Catalin
    Macfarlane, Gary J.
    Jones, Gareth T.
    Gudbjornsson, Bjorn
    Palsson, Olafur
    Wallman, Johan K.
    van der Horst-bruinsma, Irene
    Onen, Fatos
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    JOINT BONE SPINE, 2025, 92 (03)
  • [12] Adalimumab and etanercept adherence, persistence and switch in the treatment of psoriatic arthritis: 10-year real-life analysis
    Santoleri, Fiorenzo
    Romagnoli, Alessia
    Costantini, Alberto
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (01) : 93 - 97
  • [13] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 131 - 140
  • [14] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul A.
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) : 473 - 479
  • [15] Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
    Gossec, Laure
    Theander, Elke
    Chakravarty, Soumya D. D.
    Bergmans, Paul
    Lavie, Frederic
    Noel, Wim
    Sharaf, Mohamed
    Siebert, Stefan
    Smolen, Josef S. S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [16] Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA
    Hunter, Theresa
    Grabner, Michael
    Birt, Julie
    Isenberg, Keith
    Shan, Mingyang
    Teng, Chia-Chen
    Wu, Jianmin
    Griffing, Kirstin
    Lisse, Jeffrey
    Curtis, Jeffrey R.
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2863 - 2874
  • [17] Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study
    Graceffa, Dario
    Zangrilli, Arianna
    Caldarola, Giacomo
    Lora, Viviana
    Orsini, Diego
    Moretta, Gala
    Pagnanelli, Gianluca
    Provini, Alessia
    Masini, Cinzia
    Bavetta, Mauro
    Giordano, Domenico
    Richetta, Antonio
    Tolino, Ersilla
    Bianchi, Luca
    Peris, Ketty
    Sperati, Francesca
    Bonifati, Claudio
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (10) : 1383 - 1391
  • [18] HIGH NUMBER OF PREVIOUS BIOLOGIC USE AND COMORBIDITIES IN FIRST REAL WORLD SECUKINUMAB STUDY IN PSA AND AS - NON-INTERVENTIONAL, AQUILA STUDY IN GERMANY
    Kiltz, U.
    Legeler, C.
    Maier-Peuschel, M.
    Veit, J. A.
    Mann, C.
    Tony, H-P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 356 - 357
  • [19] Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study
    Azuaga, A. B.
    Frade-Sosa, B.
    Laiz, A.
    Estrada, P.
    Prior-Espanol, A.
    Horcada, L.
    Polino, L.
    Moreno, M.
    Moragues, C.
    Urruticoechea-Arana, A.
    Sellas, A.
    Tandaipan, J. L.
    Torrente-Segarra, V.
    Garcia-Miguel, J.
    Ros, I.
    Ordonez, S.
    Moya, P.
    Reina, D.
    Mateo-Soria, L.
    Fito, C.
    Beltran, E.
    Pujol, M.
    Cuervo, A. M.
    Canete, J. D.
    Ramirez, Julio
    CLINICAL RHEUMATOLOGY, 2020, 39 (10) : 2963 - 2971
  • [20] Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
    Kaeley, Gurjit S.
    Schett, Georg
    Conaghan, Philip G.
    McGonagle, Dennis
    Behrens, Frank
    Goupille, Philippe
    Gaillez, Corine
    Parikh, Bhumik
    Bakewell, Catherine
    RHEUMATOLOGY, 2024, 63 (01) : 41 - 49
12345